Predict your next investment

Thermedical company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
thermedical.com

See what CB Insights has to offer

Founded Year

2008

Stage

Loan | Alive

Total Raised

$41.45M

Last Raised

$250K | 1 yr ago

About Thermedical

Thermedical develops preclinical prototypes for Saline-Enhanced Radio Frequency (SERF) ablation systems for treating malignant solid tissue, such as liver cancer, and for difficult-to-treat cardiac arrhythmias, such as ventricular tachycardia (VT). The ablation therapy system is designed to increase survival, improve quality of life for liver cancer patients, and be a cure for VT.

Thermedical Headquarter Location

150 Bear Hill Road Second Floor

Waltham, Massachusetts, 02451,

United States

781-373-3688

Latest Thermedical News

FDA and Health Canada Approve Thermedical’s Degassed Saline to Help Reduce Risk of Stroke

Jun 16, 2020

Montreal Heart Institute First to use New Degassed Saline During Innovative Cardiac Ablation Procedure | Source: Montreal Heart Institute Dr. Katia Dyrda MONTREAL and WALTHAM, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) and Thermedical® , a developer of thermal-ablation systems to treat ventricular arrhythmias, today announced the first ablation performed using the groundbreaking Durablate® retractable needle catheter and degassed saline, which together eliminate over 98% of the air bubbles that can lead to stroke. Health Canada and the U.S. Food & Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter , currently being studied for the treatment of ventricular tachycardia (VT), a leading cause of sudden cardiac death worldwide. “Although ventricular arrhythmias cannot always be completely cured, the new SERF irrigated needle ablation technique with degassed saline solution represents a great advance for patients with extensive diseases, and for whom the next treatment options would be a heart transplant or mechanical heart,” said Dr. Katia Dyrda , associate professor of medicine, electrophysiology training program director, Montreal Heart Institute. “Moreover, this innovative procedure has the power to greatly improve the quality of life for patients, and I am extremely happy to work in a hospital that makes breakthrough treatments like this available to patients,” continued Dr. Dyrda. SERF ablation with the Durablate catheter is an effective treatment option for patients with ventricular arrhythmias that are resistant to antiarrhythmic drugs or standard ablation procedures. The reason is that Thermedical’s SERF ablation using degassed saline can reach abnormal muscle fibers deep in the heart wall where standard ablation cannot reach and where life-threatening arrhythmias are often located. In addition, Thermedical’s ablation system with degassed saline reduces air bubble volume generated during VT ablation by greater than 98%. Clinical research suggests that air bubbles may contribute to procedure-related strokes. Dr. Dyrda, who is leading Montreal Heart Institute’s participation in the SERF VT Ablation study , was the second practitioner to perform an ablation using the new technology in Canada, and the first to perform this intervention using degassed saline. To date, 11 patients have benefitted from the SERF ablation procedure at MHI and three were treated with the new degassed saline. In total, there have been 21 patients treated with SERF ablation in Canada, and five treatments also included degassed saline. “We hope to one day eliminate or reduce VT episodes in patients and, as a result, significantly improve their quality of life,” said Michael Curley , Ph.D., FHRS, co-founder and chief executive officer of Thermedical. “We are extremely encouraged by Dr. Dyrda and her success in performing ablation using our technology, and we are honored that she is the first in the world to perform it at MHI using our new degassed saline. “Further, gas released during any form of ablation therapy is a clinical concern for potential procedural-related stroke,” continued Dr. Curley. “We believe that the use of degassed saline can similarly reduce the amount of gas produced during other ablation procedures such as ablation for atrial fibrillation. We will work to demonstrate the clinical utility of degassed saline for all forms of ablation therapy, and we hope to show that it has widespread ability to reduce gas generated during ablations.” About Montreal Heart Institute Founded in 1954, the Montreal Heart Institute constantly aims for the highest standards of excellence in the cardiovascular field through its leadership in clinical and basic research, ultra-specialized care, professional training, and prevention. It houses the largest research center in Canada, the largest cardiovascular prevention center in the country, and a cardiovascular genetics center. The Institute is affiliated with the University of Montreal and has more than 2,000 employees, including 245 doctors and more than 85 researchers. About Thermedical Thermedical is a privately held company founded by Massachusetts Institute of Technology (MIT) Hyperthermia Center alumni, Michael G. Curley, Ph.D. and Patrick S. Hamilton, Ph.D., based in Waltham, Mass. Under a Massachusetts Life Sciences Center Small Business Matching Grant (SBMG) Award, multiple NIH* Small Business Innovation Research (SBIR) Grants, and Series A venture funding, the company has developed thermal-ablation systems to treat ventricular tachycardia (VT) and solid tumors. The Saline Enhanced Radiofrequency (SERF) VT Ablation Early Feasibility Study (EFS) is underway at six centers in the U.S. and Canada. For more information, visit www.thermedical.com . Media Contacts:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Thermedical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Thermedical is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

7,401 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

C

Cancer

3,592 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

B

Bioelectronics

843 items

Companies developing/using technology aimed at detecting, interpreting, interrupting, eliciting, or redirecting electrical signals within the body

Thermedical Patents

Thermedical has filed 11 patents.

The 3 most popular patent topics include:

  • Energy conversion
  • Fluid dynamics
  • Solar thermal energy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/3/2018

8/10/2021

Medical equipment, Surgery, Surgical removal procedures, Surgical procedures and techniques, Surgical instruments

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/3/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/10/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Medical equipment, Surgery, Surgical removal procedures, Surgical procedures and techniques, Surgical instruments

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Thermedical Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Thermedical Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.